Carbapenemase-producing Gram-negative bacteria: Current epidemics, antimicrobial susceptibility and treatment options

研究成果: 雜誌貢獻文章

46 引文 斯高帕斯(Scopus)

摘要

Carbapenemases, with versatile hydrolytic capacity against β-lactams, are now an important cause of resistance of Gram-negative bacteria. The genes encoding for the acquired carbapenemases are associated with a high potential for dissemination. In addition, infections due to Gram-negative bacteria with acquired carbapenemase production would lead to high clinical mortality rates. Of the acquired carbapenemases, Klebsiella pneumoniae carbapenemase (Ambler class A), Verona integron-encoded metallo-β-lactamase (Ambler class B), New Delhi metallo-β-lactamase (Ambler class B) and many OXA enzymes (OXA-23-like, OXA-24-like, OXA-48-like, OXA-58-like, class D) are considered to be responsible for the worldwide resistance epidemics. As compared with monotherapy with colistin or tigecycline, combination therapy has been shown to effectively lower case-fatality rates. However, development of new antibiotics is crucial in the present pandrug-resistant era.
原文英語
頁(從 - 到)407-425
頁數19
期刊Future Microbiology
10
發行號3
DOIs
出版狀態已發佈 - 三月 1 2015

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

指紋 深入研究「Carbapenemase-producing Gram-negative bacteria: Current epidemics, antimicrobial susceptibility and treatment options」主題。共同形成了獨特的指紋。

  • 引用此